Last reviewed · How we verify

NCT04499651: LINKHCV

Testing of a Navigation Intervention for Hepatitis C and HIV

Terminated NA Last updated 26 February 2021
What this trial tests

NA trial testing Navigation in HIV (Human Immunodeficiency Virus) in 1 participant. Terminated before completion.

Timeline
31 July 2020
Primary endpoint
22 February 2021
22 February 2021

Quick facts

Lead sponsorUniversity of California, Los Angeles
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment1
Start date31 July 2020
Primary completion22 February 2021
Estimated completion22 February 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Los Angeles

Who can join

18 and older, male only, with HIV (Human Immunodeficiency Virus) or Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the efficacy of navigation for hepatitis C treatment in people living with both HIV and HCV with criminal justice involvement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Navigation

Trials testing the same drug.

Other recruiting trials for HIV (Human Immunodeficiency Virus)

Currently open trials in the same condition.

Other University of California, Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing